Future studies should however focus not only on the presence of tolerogenic immature CD1a+ DCs in tumour tissue, but also on their functional phenotype, as this may add important information on their potential immune modulatory effect in the inflammatory tumour microenvironment. The gene discussed is CD1A; the disease is neoplasm.